Afri Can Forum 2
Table of contentsA1 Introduction to the 2nd synchronicity forum of GHRI/CHVI funded Canadian and African HIV prevention and vaccine teamsO1 Voluntary medical male circumcision for prevention of heterosexual transmission of HIV in adult males in Soweto: What do indicators and incidence rate show?Hillary Mukudu, Neil Martinson, Benn SartoriusO2 Developing a peer led community mobilization program for sex workers in Soweto: HIV risk and demographicsJenny Coetzee, Janan Dietrich, Kgaugelo Mokgatswana, Rachel Jewkes, Glenda E. GrayO3 Salient beliefs about adherence: A qualitative survey conducted as part of the demonstration study on "treatment as prevention" (TasP) and "pre exposure prophylaxis" (PrEP) among female sex workers (FSWS) in Cotonou, BeninMarylene Dugas, Luc Behanzin, Fernand A. Guedou, Marie Pierre Gagnon, Michel AlaryO4 Relative perception of risk as a driver of unsafe sexual practices among key populations: Cases of fisherfolk and women and their partners involved in multiple sexual partnerships in UgandaRwamahe Rutakumwa, Martin Mbonye, Thadeus Kiwanuka, Sarah Nakamanya, Richard Muhumuza, Winfred Nalukenge, Janet SeeleyO5 Exploring the acceptability of new biomedical HIV prevention technologies among MSM, adolescents and heterosexual adults in South AfricaMillicent Atujuna, Melissa Wallace, Ben Brown, Linda Gail Bekker, Peter A. NewmanO6 HIV susceptible target cells in foreskins after voluntary medical male circumcision in South AfricaRushil Harryparsad, Abraham J. Olivier, Heather B. Jaspan, Douglas Wilson, Janan Dietrich, Neil Martinson, Hillary Mukudu, Nonhlanhla Mkhize, Lynn Morris, Gianguido Cianci, Minh Dinh, Thomas Hope, Jo Ann S. Passmore, Clive M. GrayO7 HIV 1 proteins activate innate immune responses via TLR2 heterodimersBethany M. Henrick, Xiao Dan Yao, Kenneth L. Rosenthal, the INFANT Study TeamO8 Characterization of an innate factor in human milk and mechanisms of action against HIV 1Bethany M. Henrick, Xiao Dan Yao, Anna G. Drannik, Alash'le Abimiku, Kenneth L. Rosenthal, the INFANT Study TeamO9 Secretor status and susceptibility to HIV infections among female sex workers in Nairobi, KenyaNadia Chanzu, Walter Mwanda, Julius Oyugi, Omu AnzalaO10 Natural Killer cell recall responsiveness to Gag HIV 1 peptides of HIV 1 exposed but uninfected subjects are associated with peripheral CXCR6+ NK cell subsetsMoustapha Mbow, Sabelle Jallow, Moussa Thiam, Alberta Davis, Assane Diouf, Cheikh T. Ndour, Moussa Seydi, Tandakha N. Dieye, Souleymane Mboup, Martin Goodier, Eleanor Rilley, Assan JayeO11 Profiles of resistance: Local innate mucosal immunity to HIV 1 in commercial sex workersXiao Dan Yao, RW. Omange, Bethany M. Henrick, Richard T. Lester, Joshua Kimani, T. Blake Ball, Francis A. Plummer, Kenneth L. RosenthalO12 Early antiretroviral therapy and pre exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: A demonstration projectLuc Behanzin, Fernand A. Guedou, Nassirou Geraldo, Ella Goma Mastetse, Jerome Charles Sossa, Marcel Djimon Zannou, Michel AlaryO13 Building capacity for HIV prevention trials: Preliminary data from a Nigerian cohort of HIV exposed sero negatives (HESN)Sophia Osawe, Evaezi Okpokoro, Felicia Okolo, Stephen Umaru, Rebecca Abimiku, Sam Audu, Pam Datong, Alash'le AbimikuO14 Equipping healthcare professionals with skills required for the conduct of clinical trials in an effort to build capacity. Lessons learnedJacquelyn Nyange, Joyce Olenja, Gaudensia Mutua, Walter Jaoko, Gloria Omosa Manyonyi, Bashir Farah, Maureen Khaniri, Omu AnzalaO15 Educational technology to support active learning for HIV researchers and plannersAnne Cockcroft, Kendra Tonkin, Indu Girish, Puna Mhati, Ashley Cunningham, Neil AnderssonO16 From Lake Kivu (Rwanda) and Lake Malawi (Tanzania) to the shores of Lake Victoria (Uganda) Strengthening laboratory capacity through Good Clinical Laboratory Practice trainingBashir Farah, Jackton Indangasi, Walter Jaoko, Gaudensia Mutua, Maureen Khaniri, Jacquelyn Nyange, Omu AnzalaO17 Rilpivirine and etravirine resistance mutations in HIV 1 subtype C infected patients on a non nucleoside reverse transcriptase inhibitor based combination antiretroviral therapy in BotswanaThabo Diphoko, Simani Gaseitsiwe, Victoria Maiswe, Thato Iketleng, Dorcas Maruapula, Keabetswe Bedi, Sikhulile Moyo, Rosemary Musonda, Mark Wainberg, Joseph Makhema, Vladimir Novitsky, Richard Marlink, Max EssexO18 From home based HIV testing to initiation of treatment: The AIDS Support Organization (TASO) Experience with Home based HIV Counselling and Testing (HBHCT) among Adolescents in Uganda, 2005 2011Stephen Okoboi, Livingstone Ssali, Sam Kalibala, Josephine Birungi, Aggrey Egessa, Jonathan Wangisi, Lyavala Joanne Okullu, Celestin Bakanda, Francis Obare41 O19 Feasibility study on using real time medication monitoring among HIV infected and Tuberculosis patients in Kilimanjaro, TanzaniaI. Marion Sumari de Boer, Hadija H. Semvua, Jossy van den Boogaard, Krisanta W. Kiwango, Kennedy M. Ngowi, Pythia T. Nieuwkerk, Rob E. Aarnoutse, Ireen Kiwelu, Eva Muro, Gibson S. KibikiO20 Deaths still among sero discordant cohort in Nigeria despite Access to treatmentRuth Datiri, Grace Choji, Sophia Osawe, Evaezi Okpokoro, Felicia Okolo, Stephen Umaru, Rebecca Abimiku, Samuel Audu, Pam Datong, Alash'le AbimikuO21 Therapeutic HIV 1 vaccine trials in Denmark and Guinea BissauFomsgaard A, Karlsson I, Jensen KJ, Jensen SS, Leo Hansen C, Jespersen S, Da Silva Te D, Rodrigues CM, da Silva ZJ, Janitzek CM, Gerstoft J, Kronborg G, the WAPHIR GroupO22 Willingness to participate in a HIV vaccine Trial among HIV exposed sero negative (HESN) persons in Jos, NigeriaEvaezi Okpokoro, Sophia Osawe, Ruth Daitiri, Grace Choji, Stephen Umaru, Felicia Okolo, Pam Datong, Alash'le AbimikuO23 Clinical research volunteers' perceptions and experiences of screening for enrolment at KAVI Institute of Clinical Research, KenyaNyariki Emily, Olenja Joyce, Lorway R. Robert, Anzala AnzalaO24 Gut microbiome, HIV exposure, and vaccine responses in South African infantsKatie Viljoen, Jerome Wendoh, Elvis Kidzeru, Ulas Karaoz, Eoin Brodie, Gerrit Botha, Nicola Mulder, Clive Gray, William Cameron, Alain Stintzi, Heather Jaspan, for the INFANT study teamO25 Analysis of HIV pol diversity in the concentrated HIV epidemic in SaskatchewanPaul N. Levett, David Alexander, Naveed Gulzar, Prabvir S. Grewal, Art F. Y. Poon, Zabrina Brumme, P. Richard Harrigan, James I. Brooks, Paul A. Sandstrom, Stryker Calvez, Stephen E. Sanche, Jamie K. ScottP1 Evaluating a HIV vaccine research community engagement programme at two HIV prevention research centres in the Western CapeLeslie Swartz, Ashraf Kagee, Anthea Lesch, Zuhayr Kafaar, Anneliese De WetP2 Validating HIV acquisition risk score using a cohort HIV exposed sero negative persons in a discordant relationship in Jos, Nigeria, West AfricaEvaezi Okpokoro, Sophia Osawe, Ruth Daitiri, Grace Choji, Stephen Umaru, Felicia Okolo, Pam Datong, Alash'le AbimikuP3 Bridging the gap between adults and adolescents and youth adults (AYA) Employing a youth centred approach to investigate HIV risk among AYA in Soweto and Durban, South AfricaJanan Dietrich, Tricia Smith, Laura Cotton, Stefanie Hornschuh, Martin van der Watt, Cari L. Miller, Glenda Gray, Jenni Smit, Manjeetha Jaggernath, Thumbi Ndung'u, Mark Brockman, Angela Kaida, on behalf of the AYAZAZI study teamsP4 Neighbours to sex workers: A key population that has been ignoredMaureen Akolo, Joshua Kimani, Prof Larry Gelmon, Michael Chitwa, Justus OseroP5 Young women's access to structural support programmes in a district of BotswanaAnne Cockcroft, Nobantu Marokoane, Leagajang Kgakole, Boikhutso Maswabi, Neo Mpofu, Umaira Ansari, Neil AnderssonP6 Voices for action from peri urban Ugandan students, teachers and parents on HIV/STI prevention: Qualitative research resultsNakinobe Elizabeth, Miiro George Mukalazi, Zalwango Flavia, Nakiyingi Miiro Jessica, Kaleebu PotianoP7 Engaging Social Media as an education tool on the fly: The use of Facebook for HIV and Ebola prevention and awareness amongst adolescents in UgandaJohn Ross Semwanga, Emily Nyanzi, Saidat Namuli Musoke, Elizabeth Nakinobe, George Miiro, Edward Katongole Mbidde, Tom Lutalo, Pontiano KaleebuP8 Circulating HIV 1 subtypes among sexual minority populations in ZambiaRay Handema, Graham P. ChianzuP9 The Development of HIV Bio bank resource management to support clinical trial and Intervention research: WAPHIR experienceMoussa Thiam, Diabou Diagne Gueye, Mame K. Ndiaye, Moustapha Mbow, Birahim P. Ndiaye, Ibrahima Traore, Mamadou C. Dia, Gilleh Thomas, Coumba Tour Kane, Souleymane Mboup, Assan JayeP10 Capacity building for clinical trials as a novel approach for scaling up HIV prevention research initiatives in East Africa: achievements and challengesEmily Nyanzi, Edward Katongole Mbidde, Pontiano Kaleebu, Juliet Mpendo, Joshua Kimani, Josephine Birungi, Winnie Muyindike, Andrew KambuguP11 Community and media perspective of research; an advocacy workshop on HIV prevention researchHachizovu Sebastian, Handema Ray, Chaponda Mike, Kabuya Jean Bertin, Mulenga ModestP12 Development of a quantitative HIV 1 and HIV 2 real time PCR (qRT PCR) viral load assayMoussa Thiam, Omar Janha, Alberta Davis, Alfred Amambua Ngwa, Davis C. Nwakanma, Souleymane Mboup, Assan JayeP13 Differential effects of sex in a West African Cohort of HIV 1, HIV 2 and HIV 1/2 dual infected patients: Men are worse offSanne Jespersen, Bo Langhoff Honge, Joakim Esbjornsson, Candida Medina, David Da Silva TE, Faustino Gomes Correira, Alex Lund Laursen, Lars Ostergaard, Andreas Andersen, Peter Aaby, Christian Erikstrup, Christian Wejse, for the Bissau HIV Cohort study groupP14 HIV infected adolescents in transition from pediatric to adult HIV care in Dakar, Senegal: sample characteristics and immunological and virological profilesSiry Dieye, Moussa Sarr, Haby Sy, Helene D Mbodj, Marianne Ndiaye, Amy Ndiaye, Seydi Moussa, Assan
BMC Infectious Diseases